Equity
-€170,706
Debts exceed assets in financial year 2025.
Vaveo
Lifetime
2 annual accounts with figures on one time axispeak -€63,185 (2025)
-€63,185▲ €30,867
lowest -€114,373 (2024)
-€101,333▲ €13,039
peak -€69,373 (2024)
-€170,706▼ €101,333
€616,818▲ 8.2%
Board3 names since 2023
3 directors and 2 others
Owners3 names in the annual accounts
33.33% and 2 others
Documentsfilings and deeds
12-06-202649 days before the deadline
2025micro format
Gross margin from -€94,051 to -€63,185Loss of €101,333Registered office moved within Merksem 26-02Equity from -€69,373 to -€170,706
Key points
from the 2025 annual accountsLosses
-€215,706 in two years
The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.
Debts
€616,818 138% of the balance sheet
Financial debts 46%Suppliers 15%Other 39%
Of this, €328,475 falls due within a year.
Turnover not published (micro format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 7,654 companies had the same profile as Vaveo has now. Each dot stands for 20 companies, two years later.
84.6%
were still trading
5.8%
stopped another way
8.8%
went bankrupt
Another 0.7% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,654 companies, not a prediction for Vaveo. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
Director,
Director
- 33.33%score equity €2.5m (2025) · 2025 annual accounts of
- 33.33%equity €770,244 (2025) · 2025 annual accounts of
- 33.33%equity €493,116 (2025) · 2025 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1001282203
Registered office moved within Merksem
New registered office: Maantjessteenweg 159/1 te 2170 Merksem · Previous registered office: Maantjessteenweg 143-161, 2170 Merksem · General meeting of 28-01-2025 · Gazette deed
Incorporation
Founding capital of €45,000 · Founders: , and · Appointments: , and · published on 19-10-2023 · Gazette deed
First establishment
Maantjessteenweg 159, Antwerp
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Vaveo Antwerp | €446,113 | -€63,185 | -38.3% | - |
| PHLV Bornem | €363,992 | -€13,488 | -15.6% | - |
| APLV Bornem | €542,377 | -€19,308 | -25.6% | 0 |
| APOTHEEK ROTSELAAR-HEIKANT Rotselaar | €323,195 | -€22,855 | -17.4% | 0 |
| Apotheek RH Antwerp | €500,314 | -€34,142 | -8.7% | - |
| LIFETIME ENERGY Wommelgem | €287,751 | -€53,494 | -21.9% | - |
| PHARMIDABLE Namur | €775,771 | -€6,385 | 4.1% | - |
These companies have the same main activity as Vaveo: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €288,000 and €776,000, founded between 2023 and 2025.
Official details
Source: KBO- Status
- Active since 17-10-2023Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 1 other
- Establishment unit
- 2.351.733.0292170 Antwerp, since 17-10-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 04-12-2025
Annual accounts 2025
- €446,113▼ 10.9%
- Filing
- Filed on 12-06-2026, 49 days before the end of the filing period
Insights on Vaveo
The 2025 annual accounts show negative equity (-€170,706) and a net result of -€101,333. Its solvency ranks better than 14% of 25,301 sector peers (NACE 47, financial year 2025).
The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Vaveo
- What is the company number of Vaveo?
- The company number of Vaveo is 1001.282.203. The VAT number is the same number with BE in front: BE 1001.282.203.
- Where is Vaveo based?
- The registered office is at Maantjessteenweg 159, 2170 Antwerp.Company details
- What does Vaveo do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Vaveo?
- Vaveo is a private limited company (BV).
- When was Vaveo founded?
- Vaveo was founded on 17-10-2023.
- Is Vaveo still active?
- Yes, Vaveo is an active enterprise in the KBO register.
- What is the turnover of Vaveo?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is Vaveo profitable?
- In financial year 2025, Vaveo made a loss of €101,333.
- Where can I find the annual accounts of Vaveo?
- Vaveo filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Vaveo due?
- Vaveo must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.